- Differential Diagnosis
Drug Information for DRISDOL ERGOCALCIFEROL, USP 50,000 IU Capsule (sanofi-aventis U.S. LLC): CONTRAINDICATIONS
- CLINICAL PHARMACOLOGY
- INDICATIONS AND USAGE
- ADVERSE REACTIONS
- DOSAGE AND ADMINISTRATION
- HOW SUPPLIED
- PRINCIPAL DISPLAY PANEL - 1.25 mg capsule
- External Links Related to DRISDOL ERGOCALCIFEROL, USP 50,000 IU Capsule (sanofi-aventis U.S. LLC)
DRISDOL is contraindicated in patients with hypercalcemia, malabsorption syndrome, abnormal sensitivity to the toxic effects of vitamin D, and hypervitaminosis D.
- Drug Information Provided by National Library of Medicine (NLM).